U.S. markets open in 7 hours 3 minutes

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.660.00 (0.00%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/19/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 330.32%
S&P500 52-Week Change 333.26%
52 Week High 316.37
52 Week Low 37.21
50-Day Moving Average 39.30
200-Day Moving Average 310.28

Share Statistics

Avg Vol (3 month) 3104.77k
Avg Vol (10 day) 3171.47k
Shares Outstanding 530.4M
Implied Shares Outstanding 6N/A
Float 810.04M
% Held by Insiders 132.45%
% Held by Institutions 157.66%
Shares Short (Aug 30, 2021) 4767.39k
Short Ratio (Aug 30, 2021) 416.62
Short % of Float (Aug 30, 2021) 47.62%
Short % of Shares Outstanding (Aug 30, 2021) 43.21%
Shares Short (prior month Jul 29, 2021) 4787.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 24, 2017
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin -190.22%
Operating Margin (ttm)-193.02%

Management Effectiveness

Return on Assets (ttm)-16.50%
Return on Equity (ttm)-113.72%

Income Statement

Revenue (ttm)17.95M
Revenue Per Share (ttm)0.76
Quarterly Revenue Growth (yoy)945.50%
Gross Profit (ttm)-17.85M
EBITDA -34.03M
Net Income Avi to Common (ttm)-34.15M
Diluted EPS (ttm)-1.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)91.06M
Total Cash Per Share (mrq)3.81
Total Debt (mrq)22.4M
Total Debt/Equity (mrq)51.11
Current Ratio (mrq)2.32
Book Value Per Share (mrq)1.83

Cash Flow Statement

Operating Cash Flow (ttm)-45.39M
Levered Free Cash Flow (ttm)-37.88M